§ 13F · FUND PROFILE
ENAVATE SCIENCES GP, LLC.
AUM · $328M (13F)Positions · 7Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | SION | SIONNA THERAPEUTICS INC | 2.48M | $109M | 31.6% | ±0% |
| 2 | ZBIO | ZENAS BIOPHARMA INC | 3.92M | $99M | 28.8% | ±0% |
| 3 | IMNM | IMMUNOME INC | 3.61M | $77M | 22.2% | ±0% |
| 4 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 2.63M | $20M | 5.8% | ±0% |
| 5 | CMPX | COMPASS THERAPEUTICS INC | 7.79M | $17M | 4.9% | ±0% |
| 6 | UPB | UPSTREAM BIO INC | 2.46M | $17M | 4.9% | ±0% |
| 7 | CAMP | CAMP4 THERAPEUTICS CORP | 1.43M | $6M | 1.8% | −35% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ENAVATE SIGNAL
AC read
ENAVATE SCIENCES GP, LLC is a Other fund managing $328 million in assets. The fund runs a focused portfolio of just 7 positions.
Read the full dossier →